Nonsteroidal Antiinflammatory Drugs and the Risk of Alzheimer's Disease

in 't Veld, Bas A., Ruitenberg, Annemieke, Hofman, Albert, Launer, Lenore J., van Duijn, Cornelia M., Stijnen, Theo, Breteler, Monique M.B., Stricker, Bruno H.C.·2001·New England Journal of Medicine
DOI 10.1056/nejmoa010178

Cited by (1,000)

Items 201–300 of 1,000

  1. NF‐κB pathway: a target for preventing β‐amyloid (Aβ)‐induced neuronal damage and Aβ42 production
    Alessandra Valerio, Flora Boroni, Marina Benarese, Ilenia Sarnico, Valentina Ghisi, Laura Grazia Bresciani, Marina Ferrario, Giuseppe Borsani, PierFranco Spano, Marina Pizzi · 2006 · European Journal of Neuroscience
  2. Drug development for Alzheimer's disease: where are we now and where are we headed?
    Sabbagh, Marwan N. · 2009 · ˜The œAmerican journal of geriatric pharmacotherapy
  3. Microglial polarization: novel therapeutic mechanism against Alzheimer’s disease
    Kai Yao, Hengbing Zu · 2019 · Inflammopharmacology
  4. Secretase inhibitors and modulators for Alzheimer’s disease treatment
    Taisuke Tomita · 2009 · Expert Review of Neurotherapeutics
  5. Prevention of Dementia by Intensive Vascular Care (PreDIVA)
    Edo Richard, Esther Van den Heuvel, Eric P. Moll van Charante, Lenny Achthoven, M. Vermeulen, Patrick Bindels, Willem A. van Gool · 2009 · Alzheimer Disease & Associated Disorders
  6. Pharmacotherapeutic approaches to the treatment of Alzheimer's disease
    John B. Standridge · 2004 · Clinical Therapeutics
  7. Presenilin function and γ‐secretase activity
    Anne L. Brunkan, Alison Goate · 2005 · Journal of Neurochemistry
  8. Interleukin-10 and interleukin-6 gene polymorphisms as risk factors for Alzheimer’s disease
    Beatrice Arosio, Daria Trabattoni, Lorenza Galimberti, Paolo Bucciarelli, Francesca Romana Fasano, Carmen Calabresi, Carlo Lorenzo Cazzullo, Carlo Vergani, Giorgio Annoni, Mario Clerici · 2003 · Neurobiology of Aging
  9. Long-Term Efficacy and Safety of Celecoxib in Alzheimer’s Disease
    Hilkka S. Soininen, Christine R. West, Jeffery L. Robbins, Liviu Niculescu · 2006 · Dementia and Geriatric Cognitive Disorders
  10. Non-Cholinergic Strategies for Treating and Preventing Alzheimer??s Disease
    Pudugramam Murali Doraiswamy · 2002 · CNS Drugs
  11. The Role of Clusterin in Alzheimer’s Disease: Pathways, Pathogenesis, and Therapy
    Yu, Jin-Tai, Tan, Lan · 2012 · Molecular Neurobiology
  12. Oxidative stress: A bridge between Down's syndrome and Alzheimer's disease
    Marianna Zana, Zoltán Janka, Janos L. Kalman · 2006 · Neurobiology of Aging
  13. Modern concept of vascular cognitive impairment
    John V. Bowler · 2007 · British Medical Bulletin
  14. PK11195 labels activated microglia in Alzheimer's disease and in vivo in a mouse model using PET
    Venneti, Sriram, Lopresti, Brian J., Wang, Guoji, Hamilton, Ronald L., Mathis, Chester A., Klunk, William E., Apte, Udayan M., Wiley, Clayton A. · 2009 · Neurobiology of Aging
  15. Estrogen Action in Neuroprotection and Brain Inflammation
    Silvia Pozzi, Valeria Benedusi, Adriana C. Maggi, Elisabetta Vegeto · 2006 · Annals of the New York Academy of Sciences
  16. Drug development for alzheimer’s disease: Microglia induced neuroinflammation as a target
    Dong, Yuan, Li, Xiaoheng, Cheng, Jinbo, Hou, Lin · 2019 · International Journal of Molecular Sciences
  17. Cyclooxygenase-2 Promotes Amyloid Plaque Deposition in a Mouse Model of Alzheimer's Disease Neuropathology
    Z. Xiang, Lap Ho, Shrishailam Yemul, Z. Zhao, Patrick N. Pompl, Kevin A. Kelley, A. Dang, Wei Qing, David B. Teplow, Giulio Maria Pasinetti · 2002 · Gene Expression
  18. Neuronal oxidative damage from activated innate immunity is EP2 receptor‐dependent
    Thomas Jude Montine, Dejan Milatović, Ramesh C. Gupta, Tibor Vályi-Nagy, Jason D. Morrow, RICHARD M. BREYER · 2002 · Journal of Neurochemistry
  19. NSAID and Antioxidant Prevention of Alzheimer's Disease: Lessons from <i>In Vitro</i> and Animal Models
    COLE, GREG M., MORIHARA, TAKASHI, LIM, GISELLE P., YANG, FUSHENG, BEGUM, AYNUN, FRAUTSCHY, SALLY A. · 2004 · Annals of the New York Academy of Sciences
  20. Anti-neuroinflammatory Activity of Nobiletin on Suppression of Microglial Activation
    Yanji Cui, Jinji Wu, Sung‐Cherl Jung, Deok-Bae Park, Young‐Hee Maeng, Jeong Yun Hong, Se-Jae Kim, Sun-Ryung Lee, Soon‐Jong Kim, Sang Jeong Kim et al. · 2010 · Biological and Pharmaceutical Bulletin
  21. No Effect of Omega-3 Fatty Acid Supplementation on Cognition and Mood in Individuals with Cognitive Impairment and Probable Alzheimer’s Disease: A Randomised Controlled Trial
    Phillips, Michelle, Childs, Caroline, Calder, Philip, Rogers, Peter · 2015 · International Journal of Molecular Sciences
  22. Nutrition, Inflammation, and Cognitive Function
    Julia Wärnberǵ, Sonia Gómez‐Martínez, Javier Romeo, Ligia Esperanza Díaz, Ascensión Marcos · 2009 · Annals of the New York Academy of Sciences
  23. The Lipoxygenases: Their Regulation and Implication in Alzheimer’s Disease
    Grzegorz Arkadiusz Czapski, Kinga Czubowicz, Joanna Benigna Strosznajder, Robert Piotr Strosznajder · 2015 · Neurochemical Research
  24. Non-steroidal anti-inflammatory drugs have anti-amyloidogenic effects for Alzheimer's β-amyloid fibrils in vitro
    Mie Hirohata, Kenjiro Ono, Hironobu Naiki, Masahito Yamada · 2005 · Neuropharmacology
  25. The Future of Precision Medicine in the Cure of Alzheimer’s Disease
    Arafah, Azher, Khatoon, Saima, Rasool, Iyman, Khan, Andleeb, Rather, Mashoque Ahmad, Abujabal, Khaled Abdullah, Faqih, Yazid Abdullilah Hassan, Rashid, Hina, Rashid, Shahzada Mudasir, Bilal Ahmad, Sheikh et al. · 2023 · Biomedicines
  26. Epidemiology of Parkinson's disease
    Meike Kasten, Annabel Chade, Caroline M. Tanner · 2007 · Handbook of clinical neurology
  27. Microglial Malfunction: The Third Rail in the Development of Alzheimer's Disease
    Mhatre, Siddhita D., Tsai, Connie A., Rubin, Amanda J., James, Michelle L., Andreasson, Katrin I. · 2015 · Trends in Neurosciences
  28. Anti-inflammatories in Alzheimer’s disease—potential therapy or spurious correlate?
    Rivers-Auty, Jack, Mather, Alison E, Peters, Ruth, Lawrence, Catherine B, Brough, David · 2020 · Brain Communications
  29. Neuroinflammation in Alzheimer’s Disease
    Veronika M. Reinisch, Daniela Krause, Norbert Müller · 2014 · Springer eBooks
  30. Fibrillar Amyloid-β-Activated Human Astroglia Kill Primary Human Neurons via Neutral Sphingomyelinase: Implications for Alzheimer's Disease
    Arundhati Jana, Kalipada Pahan · 2010 · Journal of Neuroscience
  31. Vascular risk factors and Alzheimer’s disease
    David F. Cechetto, Vladimir Hachinski, Shawn Narain Whitehead · 2008 · Expert Review of Neurotherapeutics
  32. Treatment Options in Alzheimer’s Disease: Maximizing Benefit, Managing Expectations
    Martin Rhys Farlow, Michael L. Miller, Vojislav Pejović · 2008 · Dementia and Geriatric Cognitive Disorders
  33. Neuroprotection by the PGE2 EP2 receptor in permanent focal cerebral ischemia
    Dong Liu, Liejun Wu, RICHARD M. BREYER, Mark P. Mattson, Katrin I. Andreasson · 2005 · Annals of Neurology
  34. New insights into COX-2 biology and inhibition
    Paola Patrignani, Stefania Tacconelli, Maria Gina Sciulli, Marta L. Capone · 2005 · Brain Research Reviews
  35. Potential role of N-methyl-D-aspartate receptors as executors of neurodegeneration resulting from diverse insults: focus on memantine
    Gary L. Wenk, Chris G. Parsons, Wojciech Danysz · 2006 · Behavioural Pharmacology
  36. Patterns of Expression of Purinergic Receptor P2RY12, a Putative Marker for Non-Activated Microglia, in Aged and Alzheimer’s Disease Brains
    Walker, Douglas G., Tang, Tiffany M., Mendsaikhan, Anarmaa, Tooyama, Ikuo, Serrano, Geidy E., Sue, Lucia I., Beach, Thomas G., Lue, Lih-Fen · 2020 · International Journal of Molecular Sciences
  37. Neuronal death in Alzheimer’s disease and therapeutic opportunities
    Rossen Donev, Martin V. Kolev, Bruno Millet, Johannes Thome · 2009 · Journal of Cellular and Molecular Medicine
  38. Aβ42-lowering Nonsteroidal Anti-inflammatory Drugs Preserve Intramembrane Cleavage of the Amyloid Precursor Protein (APP) and ErbB-4 Receptor and Signaling through the APP Intracellular Domain
    Sascha Weggen, Jason L. Eriksen, Sarah A. Sagi, Claus U. Pietrzik, Todd Eliot Golde, Edward H. Koo · 2003 · Journal of Biological Chemistry
  39. Identification of Cathepsin B as a Mediator of Neuronal Death Induced by Aβ-activated Microglial Cells Using a Functional Genomics Approach
    Li Gan, Shiming Ye, Alan Chu, Kristin Anton, Sai-Li Yi, V.A.M. Vincent, David von Schack, Daniel J. Chin, Joseph Christopher Murray, Scott Lohr et al. · 2004 · Journal of Biological Chemistry
  40. Nonsteroidal Anti-Inflammatory Drug-Induced Fracture Nonunion: An Inhibition of Angiogenesis?
    Mark Murnaghan, Gang Li, David Marsh · 2006 · Journal of Bone and Joint Surgery
  41. Targeting innate immunity for neurodegenerative disorders of the central nervous system
    Andreasson, Katrin I., Bachstetter, Adam D., Colonna, Marco, Ginhoux, Florent, Holmes, Clive, Lamb, Bruce, Landreth, Gary, Lee, Daniel C., Low, Donovan, Lynch, Marina A. et al. · 2016 · Journal of Neurochemistry
  42. Insight into NSAID-induced membrane alterations, pathogenesis and therapeutics: Characterization of interaction of NSAIDs with phosphatidylcholine
    Lenard M. Lichtenberger, Yong Zhou, Vasanthi Jayaraman, J. Rand Doyen, Roger G. O’Neil, Elizabeth J. Dial, David E. Volk, David G. Gorenstein, Mohan Babu Boggara, Ramanan Krishnamoorti · 2012 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
  43. p-Coumaric Acid and Ursolic Acid fromCorni fructusAttenuated β-Amyloid25–35-Induced Toxicity through Regulation of the NF-κB Signaling Pathway in PC12 Cells
    Jeong-Hyun Yoon, Kumju Youn, Chi‐Tang Ho, Mukund V. Karwe, Woo‐Sik Jeong, Mira Jun · 2014 · Journal of Agricultural and Food Chemistry
  44. Aspirin and its pleiotropic application
    Jolanta Hybiak, Izabela Broniarek, Gerard Kiryczyński, Laura D. Los, Jakub Rosik, Filip Machaj, Hubert Slawinski, Kornelia Jankowska, Elżbieta Urasińska · 2019 · European Journal of Pharmacology
  45. Lipid lowering agents are associated with a slower cognitive decline in Alzheimer's disease
    I Masse · 2005 · Journal of Neurology Neurosurgery & Psychiatry
  46. Hormone replacement therapy and incidence of Alzheimer disease in older women
    2003 · Obstetrics and Gynecology
  47. NSAIDs: small molecules for prevention of Alzheimer's disease or precursors for future drug development?
    Sascha Weggen, Mark V. Rogers, Jason L. Eriksen · 2007 · Trends in Pharmacological Sciences
  48. Impact and Therapeutic Potential of PPARs in Alzheimers Disease
    Michael Thomas Heneka, Elisabet Reyes-Irisarri, Michael J. Hull, Markus P. Kummer · 2011 · Current Neuropharmacology
  49. Meta-analysis of nonsteroidal antiinflammatory drug use and risk of dementia.
    A. D. de Craen, J. Gussekloo, B. Vrijsen, R. Westendorp · 2005 · American Journal of Epidemiology
  50. Immune processes in the pathogenesis of Parkinson's disease - a potential role for microglia and nitric oxide.
    Anna Członkowska, Iwona Kurkowska‐Jastrzębska, Andrzej Członkowski, Doris Peter, George B. Stefano · 2002 · PubMed
  51. Epistasis in sporadic Alzheimer's disease
    Onofre Combarros, Mario Cortina‐Borja, A. David Smith, Donald J. Lehmann · 2008 · Neurobiology of Aging
  52. Oral apolipoprotein A-I mimetic peptide improves cognitive function and reduces amyloid burden in a mouse model of Alzheimer's disease
    Shaila P. Handattu, David W. Garber, Candyce E. Monroe, Thomas van Groen, Inga Kadish, Gaurav Nayyar, Dongfeng Cao, Mayakonda N. Palgunachari, Ling Li, G.M. Anantharamaiah · 2009 · Neurobiology of Disease
  53. Nonsteroidal anti‐inflammatory drug use and the risk of cognitive impairment and Alzheimer's disease
    Sharlène Côté, Pierre‐Hugues Carmichael, René Verreault, Joan Lindsay, Jean Lefèbvre, Danielle Laurin · 2012 · Alzheimer s & Dementia
  54. No advantage of Aβ<sub>42</sub>-lowering NSAIDs for prevention of Alzheimer dementia in six pooled cohort studies
    Szekely, C. A., Green, R. C., Breitner, J.C.S., Østbye, T., Beiser, A. S., Corrada, M. M., Dodge, H. H., Ganguli, M., Kawas, C. H., Kuller, L. H. et al. · 2008 · Neurology
  55. Deficiency in the transcription factor NRF2 worsens inflammatory parameters in a mouse model with combined tauopathy and amyloidopathy
    Ana Isabel Rojo, Marta Pajares, Ángel J. García‐Yagüe, Izaskun Buendía, Fred VAN LEUVEN, Masayuki P. Yamamoto, Manuela G. López, Antonio Cuadrado · 2018 · Redox Biology
  56. Inflammatory mechanisms in neurodegeneration
    Michael R. Nichols, Marie‐Kim St‐Pierre, Ann‐Christin Wendeln, Nyasha J. Makoni, Lisa K. Gouwens, Evan C. Garrad, Mona Sohrabi, Jonas J. Neher, Marie‐Ève Tremblay, Colin Kelly Combs · 2019 · Journal of Neurochemistry
  57. Tracking neuroinflammation in Alzheimer’s disease: the role of positron emission tomography imaging
    Zimmer, Eduardo Rigon, Leuzy, Antoine, Benedet, Andréa Lessa, Breitner, John, Gauthier, Serge, Rosa-Neto, Pedro · 2014 · Journal of Neuroinflammation
  58. The prostaglandin E2 EP2 receptor accelerates disease progression and inflammation in a model of amyotrophic lateral sclerosis
    Xibin Liang, Qian Wang, Ju Shi, Ludmila A. Lokteva, RICHARD M. BREYER, Thomas Jude Montine, Katrin I. Andreasson · 2008 · Annals of Neurology
  59. Neuroinflammation in mouse models of Alzheimer's disease
    Takashi Saito, Takaomi C. Saido · 2018 · Clinical and Experimental Neuroimmunology
  60. Disease modifying therapy for AD?<sup>1</sup>
    Golde, Todd E. · 2006 · Journal of Neurochemistry
  61. Long-Term Dietary Supplementation of Pomegranates, Figs and Dates Alleviate Neuroinflammation in a Transgenic Mouse Model of Alzheimer’s Disease
    Musthafa Mohamed Essa, Selvaraju Subash, Mohammed Danish Akbar, Samir Al‐Adawi, Gilles J. Guillemin · 2015 · PLoS ONE
  62. PRECISION MEDICINE - THE GOLDEN GATE FOR DETECTION, TREATMENT AND PREVENTION OF ALZHEIMER’S DISEASE
    Harald Juergen Hampel, Sid E. O’Bryant, Juan Ignacio Castrillo, Craig William Ritchie, Katrine Rojkova, Karl Broich, Norbert Benda, Robert Nisticò, Richard Frank, Bruno Dubois et al. · 2016 · The Journal of Prevention of Alzheimer s Disease
  63. Relation of NSAIDs to incident AD, change in cognitive function, and AD pathology
    Zoe Arvanitakis, Francine Grodstein, Julia L. Bienias, Julie A. Schneider, R. S. Wilson, Jeremiah F. Kelly, Denis A. Evans, David Alan Bennett · 2008 · Neurology
  64. Anticholinergic drug use and risk for dementia: target for dementia prevention
    Frank Jessen, Hanna Kaduszkiewicz, Moritz Daerr, Horst Bickel, Michael Pentzek, Steffi Gerlinde Riedel-Heller, Michael Wagner, Siegfried B. Weyerer, Birgitt Wiese, Hendrik van den Bussche et al. · 2010 · European Archives of Psychiatry and Clinical Neuroscience
  65. Ibuprofen attenuates oxidative damage through NOX2 inhibition in Alzheimer's disease
    Brandy L. Wilkinson, Paige E. Cramer, Nicholas H. Varvel, Erin G. Reed-Geaghan, Qingguang Jiang, Alison Szabo, Karl Herrup, Bruce T. Lamb, Gary E. Landreth · 2010 · Neurobiology of Aging
  66. Antimalarial Drug Artemisinin Extenuates Amyloidogenesis and Neuroinflammation in APP swe/ PS 1dE9 Transgenic Mice via Inhibition of Nuclear Factor‐κ B and NLRP 3 Inflammasome Activation
    Jian‐Quan Shi, Chu‐Chu Zhang, Xiu‐Lan Sun, Xin‐Xin Cheng, Jiangbo Wang, Yingdong Zhang, Jun Liang Xu, Haiqiang Zou · 2013 · CNS Neuroscience & Therapeutics
  67. INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease
    Meyer, Pierre-François, Tremblay-Mercier, Jennifer, Leoutsakos, Jeannie, Madjar, Cécile, Lafaille-Maignan, Marie-Élyse, Savard, Melissa, Rosa-Neto, Pedro, Poirier, Judes, Etienne, Pierre, Breitner, John et al. · 2019 · Neurology
  68. Statins and serum cholesterol's associations with incident dementia and mild cognitive impairment
    May A. Beydoun, Lori L. Beason‐Held, Melissa H. Kitner‐Triolo, Hind A. Beydoun, Luigi Ferrucci, Susan M. Resnick, Alan B. Zonderman · 2010 · Journal of Epidemiology & Community Health
  69. Suppression of Alzheimer-Associated Inflammation by Microglial Prostaglandin-E2EP4 Receptor Signaling
    Nathaniel S. Woodling, Qian Wang, Prachi G. Priyam, Paul B. Larkin, Ju Shi, Jenny U. Johansson, Irene A. Zagol-Ikapitte, Olivier G. Boutaud, Katrin I. Andreasson · 2014 · Journal of Neuroscience
  70. Rat brain arachidonic acid metabolism is increased by a 6‐day intracerebral ventricular infusion of bacterial lipopolysaccharide
    T. Rosenberger, N. Villacreses, J. Hovda, Francesca Bosetti, Gayani R. Weerasinghe, R. N. Wine, G. Harry, S. I. Rapoport · 2004 · Journal of Neurochemistry
  71. Peripherally Administered Human Umbilical Cord Blood Cells Reduce Parenchymal and Vascular β -Amyloid Deposits in Alzheimer Mice
    William V. Nikolic, Huayan Hou, Terrence Town, Yuyan Zhu, Brian N. Giunta, Cyndy Davis Sanberg, Jin Zeng, Deyan Luo, Jared C. Ehrhart, Takashi Mori et al. · 2008 · Stem Cells and Development
  72. Fatty Acid Oxidation in the Pathogenesis of Alzheimer's Disease
    Thomas Jude Montine, Jason D. Morrow · 2005 · American Journal Of Pathology
  73. 2-dialkylamino-6-acylmalononitrile substituted naphthalenes (DDNP analogs): novel diagnostic and therapeutic tools in Alzheimer's disease
    Eric D. Agdeppa · 2003 · Molecular Imaging and Biology
  74. A Method for Diagnosing Alzheimer’s Disease Based on Salivary Amyloid-β Protein 42 Levels
    Moon‐Hee Lee, Jian‐Ping Guo, Krista Kennedy, Edith G. McGeer, Patrick L. McGeer · 2016 · Journal of Alzheimer s Disease
  75. Neuroprotective properties of the innate immune system and bone marrow stem cells in Alzheimer's disease
    Alain R. Simard, Serge Rivest · 2006 · Molecular Psychiatry
  76. Alzheimer?s associated inflammation, potential drug targets and future therapies
    Grant Stuchbury, G. M�nch · 2004 · Journal of Neural Transmission
  77. Cyclooxygenase (COX)-2 and COX-1 Potentiate β-Amyloid Peptide Generation through Mechanisms That Involve γ-Secretase Activity
    Weiping Qin, Lap Ho, Patrick N. Pompl, Yuanzhen Peng, Zhong Zhao, Zhongmin Xiang, Nikolaos K. R K Robakis, Junichi Shioi, Jason Suh, Giulio Maria Pasinetti · 2003 · Journal of Biological Chemistry
  78. Effect of vitamins and aspirin on markers of platelet activation, oxidative stress and homocysteine in people at high risk of dementia
    VITAL Trial Collaborative Group · 2003 · Journal of Internal Medicine
  79. Reconsider Alzheimer's disease by the ‘calpain–cathepsin hypothesis’—A perspective review
    Tetsumori Yamashima · 2013 · Progress in Neurobiology
  80. Alzheimer disease: protective factors
    Fati Nourhashémi, Sophie Guyonnet, Sandrine Andrieu, Anne Ghisolfi, Pierre‐Jean Ousset, H. Grandjean, Alain Grand, Jacques Pous, Bruno J. Vellas, J. L. Albaréde · 2000 · American Journal of Clinical Nutrition
  81. The role of the immune system in neurodegenerative disorders: Adaptive or maladaptive?
    Doty, Kevin R., Guillot-Sestier, Marie-Victoire, Town, Terrence · 2015 · Brain Research
  82. An update on the efficacy of non-steroidal anti-inflammatory drugs in Alzheimer's disease
    Bruno Pietro Imbimbo · 2009 · Expert Opinion on Investigational Drugs
  83. Early Stage Drug Treatment That Normalizes Proinflammatory Cytokine Production Attenuates Synaptic Dysfunction in a Mouse Model That Exhibits Age-Dependent Progression of Alzheimer's Disease-Related Pathology
    Adam D. Bachstetter, Christopher Mark Norris, Pradoldej M Sompol, Donna M. Wilcock, Danielle S. Goulding, Janna H. Neltner, Daret K. St. Clair, Daniel Martin Watterson, Linda J. Van Eldik · 2012 · Journal of Neuroscience
  84. Cyclooxygenase inhibition targets neurons to prevent early behavioural decline in Alzheimer’s disease model mice
    Nathaniel S. Woodling, Damien Colas, Qian Wang, Paras Singh Minhas, Maharshi Panchal, Xibin Liang, Siddhita D. Mhatre, Holden D. Brown, Novie Ko, Irene A. Zagol-Ikapitte et al. · 2016 · Brain
  85. Bacteroides Fragilis in the gut microbiomes of Alzheimer’s disease activates microglia and triggers pathogenesis in neuronal C/EBPβ transgenic mice
    Xia, Yiyuan, Xiao, Yifan, Wang, Zhi-Hao, Liu, Xia, Alam, Ashfaqul M., Haran, John P., McCormick, Beth A., Shu, Xiji, Wang, Xiaochuan, Ye, Keqiang · 2023 · Nature Communications
  86. Decreased C-Reactive Protein Levels in Alzheimer Disease
    O'Bryant, Sid E., Waring, Stephen C., Hobson, Valerie, Hall, James R., Moore, Carol B., Bottiglieri, Teodoro, Massman, Paul, Diaz-Arrastia, Ramon · 2010 · Journal of Geriatric Psychiatry and Neurology
  87. Hormetic effects of curcumin: What is the evidence?
    Nazanin Sadat Aghili Moghaddam, M. N. Oskouie, A. Butler, P. Petit, G. Barreto, A. Sahebkar · 2018 · Journal of Cellular Physiology
  88. Role of Microglial Cells in Alzheimer’s Disease Tau Propagation
    Ena Španić, Lea Langer Horvat, Patrick R. Hof, Goran Šimić · 2019 · Frontiers in Aging Neuroscience
  89. Does aspirin protect against Alzheimer's dementia? A study in a Swedish population-based sample aged ?80�years
    Nilsson, Sven E., Johansson, Boo, Takkinen, Sanna, Zarit, Steven, McClearn, Gerald, Melander, Arne, Berg, Stig · 2003 · European Journal of Clinical Pharmacology
  90. The Development of New Therapeutics for Alzheimer's Disease
    M D Carter, Gordon A. Simms, Donald Fredric Weaver · 2010 · Clinical Pharmacology & Therapeutics
  91. Atorvastatin prevents hippocampal cell death, neuroinflammation and oxidative stress following amyloid-β1–40 administration in mice: Evidence for dissociation between cognitive deficits and neuronal damage
    Tetsade Piermartiri, Cláudia Pinto Figueiredo, Daniel Rial, Filipe Silveira Duarte, Sarah C. Bezerra, Gianni Mancini, Andreza Fabro De Bem, Rui Daniel Prediger, Carla I. Tasca · 2010 · Experimental Neurology
  92. Signal transduction pathways in mouse microglia N‐11 cells activated by advanced glycation endproducts (AGEs)
    Sladjana Dukić-Stefanović, Jovana Gasic‐Milenkovic, Winnie Deuther‐Conrad, Gerald W Münch · 2003 · Journal of Neurochemistry
  93. SYMPOSIUM: Clearance of Aβ from the Brain in Alzheimer' Disease: The Role of the Immune System in Clearance of Aβ from the Brain
    Delphine Boche, James A. R. Nicoll · 2008 · Brain Pathology
  94. The cell cycle in Alzheimer disease: A unique target for neuropharmacology
    Kate M. Webber, Arun K. Raina, Michael W. Marlatt, Xiongwei Zhu, María Inés Prat, Laura Morelli, Gemma Casadesús, George L. Perry, Mark A. Smith · 2005 · Mechanisms of Ageing and Development
  95. Inflammation, genes and zinc in Alzheimer's disease
    Sonya Vasto, Giuseppina Candore, Florinda Listı̀, Carmela Rita Balistreri, Giuseppina Colonna‐Romano, Marco Malavolta, Domenico Lio, Domenico Nuzzo, Eugenio Mocchegiani, Danilo Di Bona et al. · 2008 · Brain Research Reviews
  96. Role of COX-2 in Inflammatory and Degenerative Brain Diseases
    Luisa Minghetti · 2007 · Sub-cellular biochemistry/Subcellular biochemistry
  97. Small Molecule Oxidation Products Trigger Disease-Associated Protein Misfolding
    Jan Bieschke, Qinghai Zhang, Daryl A. Bosco, Richard Alan Lerner, Evan T. Powers, Paul Wentworth, Jeffery W. Kelly · 2006 · Accounts of Chemical Research
  98. APP Intracellular Domain Impairs Adult Neurogenesis in Transgenic Mice by Inducing Neuroinflammation
    Kaushik Ghosal, Andrea M. Stathopoulos, Sanjay W. Pimplikar · 2010 · PLoS ONE
  99. Oxidative stress in Alzheimer’s Disease: Implications for Prevention and Therapy
    Christian Behl · 2006 · Springer eBooks
  100. Dexamethasone protects against dopaminergic neurons damage in a mouse model of Parkinson's disease
    Kurkowska-Jastrzębska, Iwona, Litwin, Tomasz, Joniec, Ilona, Ciesielska, Agnieszka, Przybyłkowski, Adam, Członkowski, Andrzej, Członkowska, Anna · 2004 · International Immunopharmacology